For Taiwan Market
Continual growth for pharmaceutical and food supplement import: 5% growth for overseas import every year. Taiwan's pharmaceutical market will expand in value from $5.4 billion in 2013 to approximately $8.4 billion by 2020, according to a Global Data report. While for food supplements, import products still dominate the market share which is expected to remain such tendency.
Patent Drug Expiration: more drug patents will expire by 2018 wion and Taiwan is no exception so strategic pricing will be crucial.
For China Market
Registration Regulations: Registration of Drug and Medical Device in China (more costly and time consuming comparing in Taiwan) is tough due to the restrict requirements on clinical studies
Future advantage with Taiwan registration experience: Negotiation the cross-straits is undergoing for the simplified procedures for products already registered. We are optimistic about the results of negotiation have confidence in the simplified procedures for Taiwanese companies under the same system of hospital listing and same language for the seminars in China.
Global Partnership: Looking to expand